Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-18
DOI
10.1007/s10557-020-07134-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double‐blind, Placebo‐controlled Study (ENERGIZE)
- (2020) W. Frank Peacock et al. ACADEMIC EMERGENCY MEDICINE
- ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3–5: A Network Meta-Analysis of Randomised Clinical Trials
- (2020) Yaru Zhang et al. DRUGS
- Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose–response, phase 2/3 study
- (2020) Naoki Kashihara et al. Clinical and Experimental Nephrology
- Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study
- (2019) Min Jun et al. PLoS One
- Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia
- (2019) Bruce S. Spinowitz et al. Clinical Journal of the American Society of Nephrology
- A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia
- (2019) Steven Fishbane et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age
- (2019) J. Ariana Noel et al. JAMA Internal Medicine
- Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- (2019) Catherine M. Clase et al. KIDNEY INTERNATIONAL
- Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study
- (2019) Simon D Roger et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failure
- (2018) Gianluigi Savarese et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Systematic Review and Meta-Analysis of Patiromer and Sodium Zirconium Cyclosilicate: A New Armamentarium for the Treatment of Hyperkalemia
- (2017) Calvin J. Meaney et al. PHARMACOTHERAPY
- Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project
- (2017) Ghassan Bandak et al. Journal of the American Heart Association
- Potassium-Binding Agents to Facilitate Renin-Angiotensin-Aldosterone System Inhibitor Therapy
- (2016) Jared A. Schaefer et al. ANNALS OF PHARMACOTHERAPY
- Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study
- (2016) Amanda E. Hagan et al. CLINICAL NEPHROLOGY
- Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD
- (2015) L. Lepage et al. Clinical Journal of the American Society of Nephrology
- Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial
- (2015) Stefan D. Anker et al. EUROPEAN JOURNAL OF HEART FAILURE
- A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient
- (2015) Stephen R. Ash et al. KIDNEY INTERNATIONAL
- Sodium Zirconium Cyclosilicate for Urgent Therapy of Severe Hyperkalemia
- (2015) Mikhail Kosiborod et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sodium Zirconium Cyclosilicate in Hyperkalemia
- (2015) David K. Packham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes
- (2014) Jagadish Khanagavi et al. Archives of Medical Science
- Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies
- (2014) Guang Hao et al. BMC Cardiovascular Disorders
- Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia
- (2014) Mikhail Kosiborod et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Characterization of Structure and Function of ZS-9, a K+ Selective Ion Trap
- (2014) Fiona Stavros et al. PLoS One
- Prediction and Management of Hyperkalemia Across the Spectrum of Chronic Kidney Disease
- (2014) Ivana Lazich et al. SEMINARS IN NEPHROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search